Travaux scientifiques
Doç. Dr. Eren Arslan Davulcu
45 publications. La source de l’information est indiquée à côté de chaque publication.
-
(PB2953) REAL-WORLD EFFICACY AND CARDIOVASCULAR SAFETY OF ACALABRUTINIB IN B-CELL MALIGNANCIES: A TURKISH MULTICENTER EXPERIENCE COMPARING FRONTLINE INITIATION VS. TRANSITION AFTER IBRUTINIB INTOLERANCE Topic: 06. Chronic lymphocytic leukemia and related disorders -Clinical
2026
DOI 10.13140/rg.2.2.20277.44000 Source : OpenAlex
-
CLINICAL IMPACT OF ELTROMBOPAG-ASSOCIATED IRON CHELATION IN ADULTS WITH IMMUNE THROMBOCYTOPENIA: A MULTICENTER REAL-WORLD STUDY
Mediterranean Journal of Hematology and Infectious Diseases, 2026
DOI 10.4084/mjhid.2026.027 PMID 41821563 Texte intégral en libre accèsSource : ORCID
-
The Outcomes of Newly Diagnosed Multiple Myeloma Patients With Concurrent or Previous Solid Tumor History
Clinical Lymphoma Myeloma & Leukemia, 2025
DOI 10.1016/j.clml.2025.10.006 PMID 41206323 Source : OpenAlex
-
Successful Treatment with Romiplostim Following Eltrombopag-Induced Liver Injury in Primary Immune Thrombocytopenia
Turkish journal of haematology : official journal of Turkish Society of Haematology, 2025
DOI 10.4274/tjh.galenos.2025.2025.0209 PMID 40719053 Texte intégral en libre accèsSource : Europe PMC
-
Posttransplant Lymphoproliferative Disease: A Case Confused with Tuberculosis
Turkish Journal of Nephrology, 2025
DOI 10.5152/turkjnephrol.2025.24808 Texte intégral en libre accèsSource : OpenAlex
-
Real-Life Outcomes of Bosutinib in Patients with Chronic Myeloid Leukemia: A Multicenter Nationwide Study from Turkey
Blood, 2024
DOI 10.1182/blood-2024-193433 Texte intégral en libre accèsSource : OpenAlex
-
Impact of CALR and JAK2V617F Mutations on Clinical Course and Disease Outcomes in Essential Thrombocythemia: A Multicenter Retrospective Study in Turkish Patients,Esansiyel Trombositemide CALR ve JAK2V617F Mutasyonlarının Klinik Seyir ve Hastalık Sonuçlarına Etkisi: Türk Hastalarda Geriye Dönük Çok Merkezli Çalışma
Turkish Journal of Hematology, 2024
DOI 10.4274/tjh.galenos.2024.2023.0430 PMID 38433449 10 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID
-
Treatment of anemia in myelofibrosis: focusing on novel therapeutic options
Expert Opinion on Investigational Drugs, 2024
DOI 10.1080/13543784.2023.2294324 PMID 38073183 5 citations (Europe PMC) Source : ORCID
-
The assessment of health-related quality of life in patients with polycythemia vera
Medicine, 2024
DOI 10.1097/md.0000000000038814 PMID 39058813 3 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex
-
A Case of Myosin Heavy Chain 9-Related Disorder Following Splenectomy Due to Misdiagnosis of Idiopathic Thrombocytopenic Purpura
Cureus, 2024
DOI 10.7759/cureus.55064 PMID 38550428 Texte intégral en libre accèsSource : OpenAlex
-
MPN-261 A Case of Chronic Myelomonocytic Leukemia With Recurrent Skin Involvement
Clinical Lymphoma Myeloma & Leukemia, 2024
DOI 10.1016/s2152-2650(24)01419-8 Source : OpenAlex
-
A Case of Chronic Myelomonocytic Leukemia With Recurrent Skin Involvement
Clinical Lymphoma Myeloma & Leukemia, 2024
DOI 10.1016/s2152-2650(24)00718-3 Source : OpenAlex
-
Evaluation of contraception methods in chronic myeloid leukemia patients: A Turkish multicenter study
Journal of Oncology Pharmacy Practice, 2024
DOI 10.1177/10781552241280615 PMID 39221456 Source : OpenAlex
-
A Case of Chronic Myelomonocytic Leukemia With Recurrent Skin Involvement
Cureus, 2024
DOI 10.7759/cureus.75193 PMID 39759649 Texte intégral en libre accèsSource : OpenAlex
-
RETROSPECTIVE EVALUATION OF BONE MARROW FINDINGS IN AUTOIMMUNE HEMOLYTIC ANEMIAS
Hematology Transfusion and Cell Therapy, 2023
DOI 10.1016/j.htct.2023.09.068 Texte intégral en libre accèsSource : OpenAlex
-
Adult Onset Langerhans Cell Histiocytosis: Clinical Characteristics and Treatment Outcomes
Clinical Hematology International, 2023
DOI 10.1007/s44228-023-00034-w PMID 36826750 3 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID
-
Eltrombopag for the Treatment of Allogeneic Hematopoietic Stem Cell Transplantation-Related Poor Graft Function
Cureus, 2023
DOI 10.7759/cureus.44555 PMID 37790070 4 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex
-
Multimorbidities and polypharmacy in ageing hemophilia patients
Ege Tıp Dergisi, 2023
DOI 10.19161/etd.1262533 Texte intégral en libre accèsSource : OpenAlex
-
Secondary Malignancies among Myeloproliferative Neoplasms
International Journal of Clinical and Experimental Medicine Research, 2023
DOI 10.26855/ijcemr.2023.07.005 Texte intégral en libre accèsSource : OpenAlex
-
Acquired Hemophilia A In Adults: A Multicenter Study from Turkey
Indian Journal of Hematology and Blood Transfusion, 2022
DOI 10.1007/s12288-022-01556-8 PMID 36699428 3 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex
-
The Real-World Experience With Single Agent Ibrutinib in Relapsed/Refractory CLL
Clinical Lymphoma, Myeloma and Leukemia, 2022
DOI 10.1016/j.clml.2021.09.010 PMID 34629286 5 citations (Europe PMC) Source : ORCID
-
RITUXIMAB INDUCED LUNG DISEASE IN A MANTLE CELL LYMPHOMA PATIENT RECEIVING MAINTENANCE: CASE PRESENTATION
Hematology, Transfusion and Cell Therapy, 2022
DOI 10.1016/j.htct.2022.09.1245 Texte intégral en libre accèsSource : ORCID
-
Complex karyotype with double Philadelphia chromosome and T315I mutation results in blastic phase and extensive extramedullary infiltration in a chronic myeloid leukemia patient
Cancer Genetics, 2022
DOI 10.1016/j.cancergen.2022.07.002 PMID 35843036 4 citations (OpenAlex) Source : OpenAlex
-
Pralatrexate in patients with relapsed and refractory T-cell lymphomas: real world data
DergiPark (Istanbul University), 2022
DOI 10.19161/etd.1310801 Texte intégral en libre accèsSource : OpenAlex
-
Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data,Kronik Lenfositik Lösemili Hastalarda İbrutinib Tedavisinin Etkililiği ve Güvenilirliği: Gerçek Hayat Verilerinin Retrospektif Analizi
Turkish Journal of Hematology, 2021
DOI 10.4274/tjh.galenos.2021.2021.0007 PMID 34448556 5 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID
-
Ege Üniversitesi Hastanesi veri tabanında kayıtlı erişkin Hodgkin dışı lenfoma olgularının epidemiyolojik özelliklerinin retrospektif olarak değerlendirilmesi
Ege Tıp Dergisi, 2020
DOI 10.19161/etd.815316 1 citation (OpenAlex) Texte intégral en libre accèsSource : ORCID
-
Sleeve Gastrectomy in a Severe Hemophilia A Patient: One of the Very Rare Cases
Turkish journal of haematology : official journal of Turkish Society of Haematology, 2020
DOI 10.4274/tjh.galenos.2020.2020.0168 PMID 32755126 1 citation (Europe PMC) Texte intégral en libre accèsSource : Europe PMC
-
The first report of colonic involvement of angioimmunoblastic T-cell lymphoma
The Turkish Journal of Gastroenterology, 2020
DOI 10.5152/tjg.2020.19506 PMID 32519962 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex
-
CONGENITAL AFIBRINOGENEMIA WITH CORONARY ARTERY DISEASE: A RARE CASE REPORT
Haemophilia, 2020
Source : OpenAlex
-
THE ENEMY AT THE DOOR FOR THE AGING HAEMOPHILIC INDIVIDUAL: MALIGNANCIES IN ADULT HAEMOPHILIA PATIENTS
2020
Source : OpenAlex
-
POLYPHARMACY IN AGEING HAEMOPHILIA PATIENTS
2020
Source : OpenAlex
-
İntrakraniyal Kanama İle Başvuran Hemofili Olgusu: Hemofili Hastaları Sadece Faktör Eksikliğinden mi Kanar?
2020
Source : OpenAlex
-
Efficacy and Safety of Ibrutinib Use in Patients with Chronic Lymphocytic Leukemia in Real World Experiences: Results of a Prospective Multicenter Study
Blood, 2019
DOI 10.1182/blood-2019-126402 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex
-
Solid Organ Transplantasyonu Sonrası Post-Transplant Lenfoproliferatif Hastalıklar: Tek Merkez Deneyimi
Dicle Tıp Dergisi, 2019
DOI 10.5798/dicletip.661282 Texte intégral en libre accèsSource : ORCID
-
Extranasal extranodal NK/T cell lymphoma: A post‐transplantation lymphoproliferative disease
International Wound Journal, 2019
DOI 10.1111/iwj.13126 PMID 30983103 6 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex
-
PB2184 CARFILZOMIB OR POMALIDOMIDE IN PATIENTS WITH RELAPSE AND/OR REFRACTORY MULTIPLE MYELOMA: SINGLE CENTER EXPERIENCE
HemaSphere, 2019
DOI 10.1097/01.hs9.0000567216.35459.66 Texte intégral en libre accèsSource : OpenAlex
-
Multipl Miyelomda Allojeneik Kök Hücre Naklinin Yeri
Turkiye Klinikleri Hematology - Special Topics, 2019
Source : OpenAlex
-
HHV-8-Related Three Malignancies in an Immunocompetent Patient: Kaposi Sarcoma, Multisentric Castleman Disease and Primary Effusion Lymphoma
Turkiye Klinikleri Journal of Case Reports, 2019
DOI 10.5336/caserep.2019-66801 Texte intégral en libre accèsSource : OpenAlex
-
Immunosuppressive agents in hematopoietic stem cell transplantation
Trends in Transplantation, 2018
DOI 10.15761/tit.1000240 5 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex
-
Castleman’s Disease: The Experience Over 17 Years
Clinical Lymphoma Myeloma & Leukemia, 2018
DOI 10.1016/j.clml.2018.07.190 Texte intégral en libre accèsSource : OpenAlex
-
Successful Treatment of Patients with AML and MDS by Decitabine: Single Centre Experience
Clinical Lymphoma Myeloma & Leukemia, 2018
DOI 10.1016/j.clml.2018.07.171 Source : OpenAlex
-
Clinical Features and Outcomes of Solitary Plasmacytomas: Single-Center Experience from Turkey
Clinical Lymphoma Myeloma & Leukemia, 2018
DOI 10.1016/j.clml.2018.07.120 Source : OpenAlex
-
Adult Onset Langerhans Cell Histiocytosis: A Single Center Experience
Clinical Lymphoma Myeloma & Leukemia, 2018
DOI 10.1016/j.clml.2018.07.189 Source : OpenAlex
-
Transfusion in Transplantation
InTech eBooks, 2017
DOI 10.5772/intechopen.69260 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex
-
Hematopoetik Kök Hücre Naklinde Oral Komplikasyonlar
Turkiye Klinikleri Hematology - Special Topics, 2017
Source : OpenAlex